Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
6/9/2025 | $66.00 | Underperform → Neutral | BNP Paribas Exane |
2/18/2025 | $60.00 → $67.00 | Market Perform → Outperform | BMO Capital Markets |
12/17/2024 | $56.00 → $59.00 | Equal Weight → Underweight | Barclays |
5/31/2024 | $57.00 | Neutral | UBS |
3/27/2024 | $40.00 | Equal Weight | Barclays |
2/12/2024 | Outperform → Mkt Perform | Raymond James | |
11/13/2023 | Mkt Outperform → Mkt Perform | JMP Securities | |
9/26/2023 | $75.00 → $60.00 | Outperform → Market Perform | BMO Capital Markets |
4 - W. P. Carey Inc. (0001025378) (Issuer)
4 - W. P. Carey Inc. (0001025378) (Issuer)
3 - W. P. Carey Inc. (0001025378) (Issuer)
8-K - W. P. Carey Inc. (0001025378) (Filer)
8-K - W. P. Carey Inc. (0001025378) (Filer)
424B5 - W. P. Carey Inc. (0001025378) (Filer)
BNP Paribas Exane upgraded W.P. Carey from Underperform to Neutral and set a new price target of $66.00
BMO Capital Markets upgraded W.P. Carey from Market Perform to Outperform and set a new price target of $67.00 from $60.00 previously
Barclays downgraded W.P. Carey from Equal Weight to Underweight and set a new price target of $59.00 from $56.00 previously
4 - W. P. Carey Inc. (0001025378) (Issuer)
4 - W. P. Carey Inc. (0001025378) (Issuer)
4 - W. P. Carey Inc. (0001025378) (Issuer)